Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer

被引：7

作者：

Pezaro, C. J. ^{[1
]}

Omlin, A. ^{[2
,3
]}

Mastris, K. ^{[4
]}

Attard, G. ^{[6
]}

Beer, T. M. ^{[7
]}

Chi, K. N. ^{[8
,9
]}

Chowdhury, S. ^{[10
]}

Davis, I. D. ^{[11
]}

Drake, C. G. ^{[12
]}

de Bono, J. S. ^{[6
]}

Efstathiou, E. ^{[13
]}

Gravis, G. ^{[14
]}

Higano, C. S. ^{[15
]}

Hussain, M. ^{[16
]}

James, N. ^{[17
]}

Logothetis, C. J. ^{[13
,18
]}

Morgans, A. ^{[19
]}

Parker, C. ^{[20
]}

Ryan, C. J. ^{[21
]}

Saad, F. ^{[22
]}

Sartor, O. ^{[23
]}

Small, E. J. ^{[24
]}

Sternberg, C. N. ^{[25
]}

Sweeney, C. J. ^{[26
,27
]}

Tannock, I. ^{[28
]}

Tombal, B. ^{[29
]}

Gillessen, S. ^{[2
]}

机构：

[1] Eastern Hlth & Monash Univ, Melbourne, Vic, Australia

[2] Cantonal Hosp St Gallen, Dept Oncol & Haematol, St Gallen, Switzerland

[3] Univ Bern, Bern, Switzerland

[4] Europa Uomo Prostate Patients, Clayhall Ilford, England

[5] Australian & New Zealand Urogenital & Prostate Ca, Camperdown, NSW, Australia

[6] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England

[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[8] BC Canc Agcy, Vancouver, BC, Canada

[9] Univ British Columbia, Vancouver, BC, Canada

[10] Guys Hosp, Dept Med Oncol, London, England

[11] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia

[12] Columbia Univ, Med Ctr, Div Haematol Oncol, New York, NY USA

[13] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA

[14] Inst Paoli Calmette, Dept Canc Med, Marseille, France

[15] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[16] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[17] Univ Birmingham, Queen Elizabeth Hosp Birmingham, Clin Oncol Unit, Birmingham, W Midlands, England

[18] Univ Athens, Alexandra Hosp, David H Koch Ctr, Dept Clin Therapeut, Athens, Greece

[19] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN USA

[20] Royal Marsden NHS Fdn Trust, Clin Oncol Acad Unit, London, England

[21] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Clin Med & Urol, San Francisco, CA 94143 USA

[22] CHU Montreal, Dept Surg, Montreal, PQ, Canada

[23] Tulane Canc Ctr, Dept Med & Urol, New Orleans, LA USA

[24] Univ Calif San Francisco, Dept Med, San Francisco, CA USA

[25] San Camillo Forlanini Hosp, Dept Med Oncol, Rome, Italy

[26] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[27] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA

[28] Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON, Canada

[29] Clin Univ St Luc, Brussels, Belgium

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷 / 08期

关键词：

TRIALS WORKING GROUP; CLINICAL-TRIALS; RECOMMENDATIONS; ENZALUTAMIDE; ABIRATERONE; CHEMOTHERAPY; GUIDELINES; THERAPY; DESIGN;

D O I：

10.1093/annonc/mdx312

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1692 / 1694

页数：4

共 17 条

[1]

Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095

[2] Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group [J].

Bubley, GJ ;

Carducci, M ;

Dahut, W ;

Dawson, N ;

Daliani, D ;

Eisenberger, M ;

Figg, WD ;

Freidlin, B ;

Halabi, S ;

Hudes, G ;

Hussain, M ;

Kaplan, R ;

Myers, C ;

Oh, W ;

Petrylak, DP ;

Reed, E ;

Roth, B ;

Sartor, O ;

Scher, H ;

Simons, J ;

Sinibaldi, V ;

Small, EJ ;

Smith, MR ;

Trump, DL ;

Vollmer, R ;

Wilding, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3461-3467

[3] Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer [J].

Buttigliero, Consuelo ;

Tucci, Marcello ;

Bertaglia, Valentina ;

Vignani, Francesca ;

Bironzo, Paolo ;

Di Maio, Massimo ;

Scagliotti, Giorgio Vittorio .

CANCER TREATMENT REVIEWS, 2015, 41 (10) :884-892

[4] 1st International consensus guidelines for advanced breast cancer (ABC 1) [J].

Cardoso, F. ;

Costa, A. ;

Norton, L. ;

Cameron, D. ;

Cufer, T. ;

Fallowfield, L. ;

Francis, P. ;

Gligorov, J. ;

Kyriakides, S. ;

Lin, N. ;

Pagani, O. ;

Senkus, E. ;

Thomssen, C. ;

Aapro, M. ;

Bergh, J. ;

Di Leo, A. ;

El Saghir, N. ;

Ganz, P. A. ;

Gelmon, K. ;

Goldhirsch, A. ;

Harbeck, N. ;

Houssami, N. ;

Hudis, C. ;

Kaufman, B. ;

Leadbeater, M. ;

Mayer, M. ;

Rodger, A. ;

Rugo, H. ;

Sacchini, V. ;

Sledge, G. ;

van't Veer, L. ;

Viale, G. ;

Krop, I. ;

Winer, E. .

BREAST, 2012, 21 (03) :242-252

[5] Castration-Resistant Prostate Cancer: Descriptive Yet Pejorative? [J].

Crawford, E. David ;

Petrylak, Daniel .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) :E408-E408

[6] Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer [J].

Ferraldeschi, R. ;

Pezaro, C. ;

Karavasilis, V. ;

de Bono, J. .

ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 :1-13

[7]

Fizazi N, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa:1704174, DOI 10.1056/NEJMOA:1704174.]

[8]

James N, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1702900, DOI 10.1056/NEJMOA1702900.]

[9] Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial [J].

James, Nicholas D. ;

Sydes, Matthew R. ;

Clarke, Noel W. ;

Mason, Malcolm D. ;

Dearnaley, David P. ;

Spears, Melissa R. ;

Ritchie, Alastair W. S. ;

Parker, Christopher C. ;

Russell, J. Martin ;

Attard, Gerhardt ;

de Bono, Johann ;

Cross, William ;

Jones, Rob J. ;

Thalmann, George ;

Amos, Claire ;

Matheson, David ;

Millman, Robin ;

Alzouebi, Mymoona ;

Beesley, Sharon ;

Birtle, Alison J. ;

Brock, Susannah ;

Cathomas, Richard ;

Chakraborti, Prabir ;

Chowdhury, Simon ;

Cook, Audrey ;

Elliott, Tony ;

Gale, Joanna ;

Gibbs, Stephanie ;

Graham, John D. ;

Hetherington, John ;

Hughes, Robert ;

Laing, Robert ;

McKinna, Fiona ;

McLaren, Duncan B. ;

O'Sullivan, Joe M. ;

Parikh, Omi ;

Peedell, Clive ;

Protheroe, Andrew ;

Robinson, Angus J. ;

Srihari, Narayanan ;

Srinivasan, Rajaguru ;

Staffurth, John ;

Sundar, Santhanam ;

Tolan, Shaun ;

Tsang, David ;

Wagstaff, John ;

Parmar, Mahesh K. B. .

LANCET, 2016, 387 (10024) :1163-1177

[10] Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach [J].

Morgans, Alicia K. ;

van Bommel, Annelotte C. M. ;

Stowell, Caleb ;

Abrahm, Janet L. ;

Basch, Ethan ;

Bekelman, Justin E. ;

Berry, Donna L. ;

Bossi, Alberto ;

Davis, Ian D. ;

de Reijke, Theo M. ;

Denis, Louis J. ;

Evans, Sue M. ;

Fleshner, Neil E. ;

George, Daniel J. ;

Kiefert, Jim ;

Lin, Daniel W. ;

Matthew, Andrew G. ;

McDermott, Ray ;

Payne, Heather ;

Roos, Ian A. G. ;

Schrag, Deborah ;

Steuber, Thomas ;

Tombal, Bertrand ;

van Basten, Jean-Paul ;

van der Hoeven, Jacobus J. M. ;

Penson, David F. .

EUROPEAN UROLOGY, 2015, 68 (05) :891-898

← 1 2 →